We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in GreenLight Biosciences Holdings, PBC Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 48 → 0 (-48)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $9.16M → $0 (-$9.16M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 48

Holders
–
Holders Change
-48
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
48
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$2.74M
2
CGC
Continental Grain Company
New York
-$1.95M
3
TCM
Tao Capital Management
California
-$802K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$513K
5
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$503K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
– -$2.74M -9,188,659 Closed
CGC
2
Continental Grain Company
New York
– -$1.95M -6,489,242 Closed
TCM
3
Tao Capital Management
California
– -$802K -2,671,664 Closed
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
– -$513K -1,720,199 Closed
BOTOTLSJU
5
Board of Trustees of The Leland Stanford Junior University
California
– -$503K -1,687,374 Closed
BlackRock
6
BlackRock
New York
– -$467K -1,565,869 Closed
BNP Paribas Asset Management
7
BNP Paribas Asset Management
France
– -$378K -1,269,179 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$300K -1,005,419 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
– -$250K -837,022 Closed
CM
10
Crystalline Management
Canada
– -$231K -775,000 Closed
BCM
11
Beryl Capital Management
California
– -$162K -544,629 Closed
Millennium Management
12
Millennium Management
New York
– -$111K -370,759 Closed
Charles Schwab
13
Charles Schwab
California
– -$109K -366,666 Closed
PCM
14
PenderFund Capital Management
British Columbia, Canada
– -$131K -331,110 Closed
YIH
15
Y-Intercept (HK)
Hong Kong
– -$73.9K -247,816 Closed
State Street
16
State Street
Massachusetts
– -$71.5K -239,831 Closed
Northern Trust
17
Northern Trust
Illinois
– -$48.9K -164,140 Closed
Goldman Sachs
18
Goldman Sachs
New York
– -$44.9K -150,579 Closed
Renaissance Technologies
19
Renaissance Technologies
New York
– -$39K -131,049 Closed
Qube Research & Technologies (QRT)
20
Qube Research & Technologies (QRT)
United Kingdom
– -$35K -117,414 Closed
CWM
21
Congress Wealth Management
Massachusetts
– -$26.8K -90,000 Closed
E
22
Ergoteles
New York
– -$26.5K -88,900 Closed
Morgan Stanley
23
Morgan Stanley
New York
– -$20.4K -68,557 Closed
JC
24
JBF Capital
Colorado
– -$14.9K -50,000 Closed
HP
25
Harbourvest Partners
Massachusetts
– -$14.6K -48,835 Closed
1
2

GRNA Hedge Fund Activity: Q3 2023 in Review

0 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q3 2023, worth a combined $0 — down 100% from $9.16M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of GRNA and 0 opened new positions — a net loss of 48 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Cormorant Asset Management, exiting entirely with an estimated $2.74M sold.

  • 0 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q3 2023, down from 48 in Q2 2023.
  • Funds reported $0 of GreenLight Biosciences Holdings, PBC Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q3 2023 and 48 closed out, a net change of -48 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q3 2023 was Cormorant Asset Management, an estimated $2.74M sold.

Based on aggregated 13F filings for Q3 2023.